Assertio Holdings ISIN: US04546C2052 Forum: Aktien User: Summer.76
0,8859 USD
+5,09 %+0,0429
21. Dec, 02:00:00 Uhr,
Nasdaq
Kommentare 36
Summer.76,
09.05.2023 16:07 Uhr
0
ASSERTIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS, RAISES FULL YEAR 2023 OUTLOOK
https://investor.assertiotx.com/news/news-details/2023/Assertio-Reports-First-Quarter-2023-Financial-Results-Raises-Full-Year-2023-Outlook/default.aspx
Summer.76,
25.04.2023 16:55 Uhr
0
https://finance.yahoo.com/news/assertio-holdings-inc-acquire-spectrum-100000644.html
G
GlobalTrust,
25.04.2023 16:53 Uhr
1
Did you see the fusion with **** pharma?
Summer.76,
24.04.2023 17:45 Uhr
0
https://finance.yahoo.com/news/assertio-provides-educational-grant-lennox-130000477.html
Summer.76,
09.03.2023 16:04 Uhr
0
🍀
Summer.76,
08.03.2023 22:03 Uhr
0
ASSERTIO REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS
https://investor.assertiotx.com/news/news-details/2023/Assertio-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-Results/default.aspx
Net Product Sales Increase 55% in the Fourth Quarter, 42% for the Full Year
Full Year Net Income Increases to $109.6 Million, Non-GAAP Adjusted EBITDA Increases to $101.6 Million
Cash Flows from Operations Was $26.7 Million for the Fourth Quarter and $78.6 Million for the Full Year
Summer.76,
26.02.2023 18:54 Uhr
0
Assertio Holdings: Compelling Income Opportunity Apart From Upside Potential
https://seekingalpha.com/article/4581797-assertio-holdings-compelling-income-opportunity-apart-from-upside-potential
Summary
• Q4 preliminary results illustrate the best product sales quarter for the past 5 years.
• Technicals, valuation, and profitability trends all point to rising prices for the stock.
• An aggressive covered call strategy is an excellent play here for both income and capital appreciation purposes.
...
Summer.76,
23.02.2023 17:58 Uhr
0
Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027
https://finance.yahoo.com/news/assertio-announces-exchange-offer-30-121400733.html
Summer.76,
21.02.2023 15:43 Uhr
0
https://finance.yahoo.com/news/assertio-holdings-inc-announces-preliminary-120000679.html
Summer.76,
22.01.2023 15:15 Uhr
0
https://seekingalpha.com/article/4571315-assertio-holdings-scores-with-new-broadly-covered-asset
Assertio Holdings Scores With New Broadly-Covered Asset
Summary
• Assertio Holdings, Inc. got the rights to Sympazan in October.
• Most Medicare plans cover it.
• Meanwhile, Assertio Holdings, Inc.'s lead product Indocin is a favored brand by the nation's #1 health insurance company.
...
Summer.76,
10.01.2023 16:56 Uhr
0
https://www.globenewswire.com/news-release/2023/01/09/2585674/0/en/Assertio-Holdings-Inc-Announces-FDA-Orange-Book-Listing-for-New-Sympazan-Oral-Film-Patent.html
Summer.76,
13.12.2022 21:01 Uhr
0
https://investor.assertiotx.com/news/news-details/2022/Assertio-Holdings-Inc.-to-Host-Investor-and-Business-Development-Meetings-January-9-11-2023-in-San-Francisco/default.aspx
Summer.76,
05.12.2022 16:21 Uhr
0
https://finance.yahoo.com/news/assertio-increases-full-net-product-123000490.html
Summer.76,
09.11.2022 5:40 Uhr
0
Assertio Reports Third Quarter 2022 Financial Results
https://finance.yahoo.com/news/assertio-reports-third-quarter-2022-210100129.html
Net Product Sales Increase 32% Year-Over-Year, Non-GAAP Adjusted EBITDA Increases 36%
Increases Guidance for Net Product Sales and Adjusted EBITDA
Debt Refinancing Extends Maturity, Reduces Cost and Increases Strategic Flexibility
Expects Sympazan to Add $1 Million in Net Product Sales in 4Q
Summer.76,
27.10.2022 17:49 Uhr
0
Assertio Holdings, Inc. Signs Exclusive License for Sympazan® (clobazam) Oral Film from Aquestive Therapeutics, Inc.
https://www.globenewswire.com/news-release/2022/10/27/2542885/0/en/Assertio-Holdings-Inc-Signs-Exclusive-License-for-Sympazan-clobazam-Oral-Film-from-Aquestive-Therapeutics-Inc.html
Trailing 12 Month Revenues of Sympazan Were $9.5 Million
Assertio Paid $9.0 Million Upfront, Additional $6.0 Million upon Patent Allowance
Summer.76,
25.08.2022 16:53 Uhr
0
https://www.globenewswire.com/news-release/2022/08/25/2504787/0/en/Assertio-Announces-Closing-of-70-Million-Convertible-Senior-Notes-Offering.html
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Dax Prognose | -0,40 % | |
2 | AFC ENERGY Hauptdiskussion | +0,18 % | |
3 | ATOS Hauptdiskussion | +4,76 % | |
4 | Leo Lithium Hauptdiskussion | +633,50 % | |
5 | INTEL Hauptdiskussion | +0,05 % | |
6 | VALNEVA SE Hauptdiskussion | +0,20 % | |
7 | Hims & Hers Health Registered (A) Hauptdiskussion | ±0,00 % | |
8 | Lilium Aktie | -56,91 % | |
9 | CLINUVEL PHARMACEUTICALS Hauptdiskussion | ±0,00 % | |
10 | STANDARD LITHIUM Hauptdiskussion | ±0,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | AFC ENERGY Hauptdiskussion | +0,18 % | |
2 | ATOS Hauptdiskussion | +4,76 % | |
3 | INTEL Hauptdiskussion | +0,05 % | |
4 | Leo Lithium Hauptdiskussion | +633,50 % | |
5 | VALNEVA SE Hauptdiskussion | +0,20 % | |
6 | Hims & Hers Health Registered (A) Hauptdiskussion | ±0,00 % | |
7 | Lilium Aktie | -56,91 % | |
8 | CLINUVEL PHARMACEUTICALS Hauptdiskussion | ±0,00 % | |
9 | STANDARD LITHIUM Hauptdiskussion | ±0,00 % | |
10 | Themen rund um ATOS | +4,76 % | Alle Diskussionen |